Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (191-200 of 298) with videos related to

Pageof 30
Sort By:
Idcases|April 8, 2022
Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and reviewCarolt Arana, Frederic Cofan, Pablo Ruiz, et al.
Annals of Hematology|December 31, 2016
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapyIvan Dlouhy, Miguel Á Torrente, Sabela Lens, et al.
Journal of Medical Virology|February 2, 2023
Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat programAnna Not, Verónica Saludes, Mont Gálvez, et al.
Gastroenterologia Y Hepatologia|November 26, 2022
Clinical practice guidelines of the Catalan Society of Gastroenterology about hepatic elastography 2022José Antonio Carrión, Isabel Graupera, Mercedes Vergara, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatmentJavier Ampuero, José Antonio Del Campo, Lourdes Rojas, et al.
Scientific Reports|September 7, 2017
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C PatientsAinara Cano, Zoe Mariño, Oscar Millet, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 10, 2026
Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapySonia Pernas, Xavier Forns, Olga Martínez-Sáez, et al.
Gastroenterology|November 3, 2004
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsHolger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, et al.
Gut|December 19, 2025
Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawalSabela Lens, Alice R Burton, Jessica Davies, et al.
World Journal of Gastroenterology|May 9, 2015
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CSabela Lens, Jose L Calleja, Ana Campillo, et al.
Pageof 30

Showing results (191-200 of 298) with videos related to

Sort By:
Pageof 30
Idcases|April 8, 2022
Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and reviewCarolt Arana, Frederic Cofan, Pablo Ruiz, et al.
Annals of Hematology|December 31, 2016
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapyIvan Dlouhy, Miguel Á Torrente, Sabela Lens, et al.
Journal of Medical Virology|February 2, 2023
Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat programAnna Not, Verónica Saludes, Mont Gálvez, et al.
Gastroenterologia Y Hepatologia|November 26, 2022
Clinical practice guidelines of the Catalan Society of Gastroenterology about hepatic elastography 2022José Antonio Carrión, Isabel Graupera, Mercedes Vergara, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatmentJavier Ampuero, José Antonio Del Campo, Lourdes Rojas, et al.
Scientific Reports|September 7, 2017
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C PatientsAinara Cano, Zoe Mariño, Oscar Millet, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 10, 2026
Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapySonia Pernas, Xavier Forns, Olga Martínez-Sáez, et al.
Gastroenterology|November 3, 2004
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsHolger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, et al.
Gut|December 19, 2025
Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawalSabela Lens, Alice R Burton, Jessica Davies, et al.
World Journal of Gastroenterology|May 9, 2015
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CSabela Lens, Jose L Calleja, Ana Campillo, et al.
Pageof 30